The Capital Infusion League Table

This probably looks really good on a Bloomberg screen, but the formatting is all screwy online. (Weirdly, the credit-loss league table looks fine.) So as a public service I’ll republish today’s league table here in a slightly easier-to-read format. Suffice to say, this is one league table you really don’t want to top.

Firm Total Infusion ($bn) Breakdown ($bn) Investor
Citigroup 30.4 6.9 Government of Singapore

Investment Corp.

    5.6 Kuwait Investment Authority, Alwaleed bin Talal, Capital

Research, Capital World, Sandy Weill, public investors

    7.5 Abu Dhabi Investment


    10.4 Public investors
UBS 27.7 10.9 Government of Singapore

Investment Corp.

    2 Unidentified Middle Eastern


    14.8 Public investors
IKB Deutsche 13.2   German government, Banking associations
Bank of America 13   Public investors
Merrill Lynch 12.2 6.6 Korea Investment Corp.,

Kuwait Investment Authority,

Mizuho Financial Group

    4.4 Temasek Holdings
    1.2 Davis Selected Advisors
Societe Generale 8.7   Public investors
WestLB 7.8   State of North Rhine Westphalia,

savings banks associations,

regional governments

Morgan Stanley 5   China Investment Corp.
Barclays 5 3 China Development Bank
    2 Temasek Holdings
Lehman Brothers 4   Public investors
Wachovia 3.5   U.S. investors (unidentified)
Canadian Imperial 2.9 1.5 Li Ka-Shing, Manulife

Imperial Financial, Caisse de Depot

et Placement du Quebec, OMERS

    1.4 Public investors
Gulf Int’l 1   Governments of Bahrain, Kuwait,

Oman, Qatar, Saudi Arabia, UAE

TOTAL 135.8    

(Via CR)

This entry was posted in banking. Bookmark the permalink.